ArticleJournal of gastrointestinal oncology2022

Cost-effectiveness of camrelizumab versus chemotherapy for the treatment of advanced or metastatic esophageal squamous cell carcinoma.

Lizong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.